URI:
   DIR Return Create A Forum - Home
       ---------------------------------------------------------
       Road2HardCoreIron
  HTML https://road2hardcoreiron.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: Steriod Profiles
       *****************************************************
       #Post#: 309--------------------------------------------------
       Equipoise (Boldenone) AKA EQ
       By: Road2HardCoreIron Date: May 25, 2018, 6:45 pm
       ---------------------------------------------------------
       Equipoise (Boldenone)
       Overview and History of Equipoise
       Equipoise is the brand/trade name for the anabolic steroid
       Boldenone, which is an oil-based injectable anabolic steroid
       with the Undecylenate ester attached to it for a prolonged
       release rate and half-life. It is a derivative of Testosterone
       that retains Testosterone’s anabolic strength but exhibits a
       reduced androgenic effect in comparison. Equipoise is primarily
       a veterinary product, originally intended for use in animals.
       Equipoise has gained popularity with bodybuilders and athletes
       as a less androgenic form of Testosterone with less Estrogenic
       activity than Testosterone as well. Many users enjoy comparing
       it to that of Nandrolone (Deca Durabolin), however, this
       comparison is a very poor one seeing as though Nandrolone
       exhibits different properties than Equipoise and is also a
       totally different class of compounds (a 19-nor, also known as a
       progestin). However, many consider Nandrolone and Equipoise to
       be a solid substitute for one another in any given cycle.
       A few interesting facts first about this compound: Equipoise was
       in fact developed in 1949, even before Dianabol
       (Methandrostenolone), making Equipoise technically the very
       first synthetic derivative of Testosterone even before Dianabol
       was ever thought of. Furthermore, Dianabol itself is actually
       Equipoise (Boldenone) with a methyl group attached to its
       17-beta hydroxyl group on the steroid chemical structure (also
       known as C17-alpha alkylation) in order to allow it to become
       orally bioavailable in the body. Technically, Dianabol
       (Methandrostenolone) is actually C17-alpha alkylated Equipoise.
       It would have been considered an oral form of Equipoise, but the
       methylation at the 17th carbon atom changed enough of the
       properties of the compound that it was considered a totally
       different anabolic steroid analogue, and named
       Methandrostenolone (Dianabol). If pictures of the chemical
       structures of Equipoise and Dianabol were laid out side by side,
       one would easily be able to tell the exact same chemical
       structure between the two, with the exception of the methyl
       group affixed to the 17th carbon on the Dianabol chemical
       structure. It is very evident that these two anabolic steroids
       are essentially the exact same.
       Although Equipoise was first developed in 1949, it was not until
       the 1960s when this compound would be finally released and
       marketed as Parenabol. Between 1949 and its release in the
       1960s, Ciba had toyed around with Equipoise by attempting to
       affix different esters onto it in order to augment its half-life
       and release rates. The final conclusion was that it would be
       released with the Undecylenate ester attached to it, and the
       final preparation was that of Boldenone Undecylenate. Following
       the release of Parenabol, various clinical trials and testing of
       this compound was conducted in the late 1960s and early 1970s
       with the goal in mind to use it as a lean mass promoting and
       preserving anabolic steroid in order to treat individuals
       suffering from any condition in which wasting and weight loss
       were symptoms, as well as an osteoporosis treatment. Parenabol
       saw very little application or use following its release, and
       towards the end of the 1970s, it was removed from the market and
       discontinued.
       Squibb would then pick up the patents for this anabolic steroid
       and re-release Boldenone under the name Equipoise as a
       veterinary anabolic steroid meant primarily for application in
       horses but is also intended for use in other animals. Equipoise
       is well known for its lean mass increases as well as its
       appetite-stimulant effects, which is an effect common among
       nearly all anabolic steroids. However, Equipoise tends to
       stimulate the appetite to far greater degrees than any other
       anabolic steroids. Although the manufacture and marketing of
       Equipoise has changed many hands over the years, it still
       remains available on the American market as well as
       internationally with plenty of generic brands as well as actual
       brand names available.
       Chemical Characteristics of Equipoise
       As previously mentioned, Equipoise is a synthetic derivative of
       Testosterone where it has been modified at carbon 1 and carbon 2
       on the steroid structure, where double-bonds have been added
       between these two carbon atoms. This is what is known as the
       modification that is responsible for reducing Equipoise’s
       affinity for interaction with the aromatase enzyme (the enzyme
       responsible for the conversion of androgens into Estrogen). As a
       result, its Estrogenic activity is regarded to be lower than
       Testosterone. Equipoise is Boldenone with the Undecylenate ester
       attached to it. Specifically, ‘Undecylenate’ is Undecylenoic
       acid, but once bound to Boldenone it is properly referred to in
       chemistry as an ester bond (or ester linkage). Undecylenoic acid
       is chemically bonded to the 17-beta hydroxyl group on the
       Boldenone structure.  The addition of this ester augments the
       hormone’s release rate and half-life to favor a longer window of
       release. The primary reason for the augmentation of its
       half-life and release rate is because once Boldenone
       Undecylenate enters the bloodstream, enzymes work to break the
       bond between the ester and the hormone, which takes a varying
       amount of time. The end result is that of the ester being
       removed from the hormone by these enzymes, and the result
       following this is pure Boldenone that is free to do its work in
       the body. This process of enzymes removing the ester from the
       hormone to which it is attached is what is responsible for the
       slower release rates. When the Undecylenate ester is attached to
       Boldenone, creating Boldenone Undecylenate, the half-life of
       Boldenone is now extended to 14 days, providing a slower release
       and activity of the hormone than the hormone otherwise would
       without this ester.
       Additionally, as noted near the beginning of this section,
       Equipoise and Dianabol are structurally identical with the only
       difference between the two being that Equipoise contains a the
       Undecylenate ester attached to its 17-beta hydroxyl group, and
       Dianabol instead contains a methyl group attached to its 17-beta
       hydroxyl group. Dianabol contains the methyl group (also known
       as C17-alpha alkylation) in order to prevent it from being
       metabolized and broken down by the liver through oral ingestion.
       Aside from these modifications, the two hormones are exactly
       identical and would be considered the exact same compounds.
       However, both of these hormones act significantly different from
       one another in the body, which is a very strong indication that
       the addition of a methyl group (C17-alpha alkylation) to the
       17th carbon does more than just affect the hormone’s resistance
       to breakdown in the liver – it actually changes the effects and
       properties of the anabolic steroid.
       Properties of Equipoise
       Equipoise being a derivative of Testosterone grants it many of
       the same properties. For one thing, it possesses the exact same
       anabolic strength rating (100), and it is also an aromatizable
       anabolic steroid, which means that Equipoise can and does
       convert into Estrogen in the body through interaction with the
       aromatase enzyme. However, its double-bond modifications between
       carbons 1 and 2 reduce its affinity for the aromatase enzyme,
       granting it a lower rate of aromatization and therefore a lower
       Estrogenic activity in the body.
       What this means is that Equipoise will still convert into
       Estrogen, but at a far less significant amount than its parent
       hormone Testosterone. Although this is a very comforting fact
       and a pleasing property, the issue of Estrogenic side effects is
       still an issue and should not be ignored by any users.
       Therefore, individuals can expect not an elimination of
       potential water retention, but a vast difference in a reduction
       of it from Equipoise alone. Although at sensible and moderate
       doses, Equipoise should not exhibit bloating or any other
       estrogenic effects (depending on user sensitivity), the risk of
       these Estrogenic side effects will indeed increase as higher and
       higher doses of Equipoise are used. Increasing doses will mean
       increased rates of aromatization of the anabolic steroid into
       Estrogen.
       Equipoise itself possesses a low androgenic strength rating
       (lower than its progenitor hormone Testosterone), which should
       be pleasing to individuals whom are sensitive to any number of
       androgenic side effects. Overall, individuals utilizing
       Equipoise can expect the same anabolic size, strength, and mass
       gains that would come from Testosterone with a lower incidence
       of Estrogenic activity and androgenic side effects. This means
       that gains from Equipoise itself should, for the most part, be
       fairly solid lean mass gains with minimal water retention
       (depending on dose) and would be a perfect addition to any
       bulking or lean mass cycle. It would even work as an appropriate
       replacement for Nandrolone in any stack.
       Equipoise Side Effects
       As previously mentioned, Equipoise expresses a lesser degree of
       estrogenic activity in the body than Testosterone itself.
       Studies have demonstrated that approximately half of the
       aromatization rate is experienced in the body with EQ as
       compared with Testosterone. Thus, the magnitude of
       Estrogen-related side effects with Equipoise should be
       significantly lower than Testosterone, but it is important to
       note that its estrogenic activity is still higher than
       Nandrolone (Deca) by a small degree. Of course, if dosages rise,
       then aromatization (and subsequently, estrogenic effects) will
       rise in proportion. Usually Equipoise dosages rising above 200 –
       400mg per week will result in observable increases in estrogenic
       side effects. Anti-estrogens and aromatase inhibitors may be
       necessary in these cases to stave off and ward off these side
       effects. Estrogenic side effects can include: water retention
       and bloating, increases in blood pressure (resultant from water
       retention), increased fat gain/retention, and potential
       development of gynecomastia.
       Androgenic side effects, although much lesser than Testosterone,
       are still a possibility with Equipoise. Although Equipoise
       interacts with the 5AR (5-alpha reductase) enzyme, which is the
       enzyme responsible for the conversion of Testosterone into the
       stronger androgen DHT (Dihydrotestosterone), it does not convert
       into DHT but instead converts into Dihydroboldenone (DHB).
       Although it converts into DHB, studies have found Equipoise to
       undergo this conversion at a much lower rate than the conversion
       of Testosterone into DHT. Androgenic side effects can include:
       increased oily skin (sebum secretion), increased acne formation
       (linked to sebum secretion), bodily and facial hair growth, and
       the increased risk of experiencing male pattern baldness (MPB)
       if the individual possesses the genetic predisposition for it.
       Equipoise is not liver toxic, and it does express the same
       degree of cardiovascular risks and endogenous Testosterone
       production suppression as most anabolic steroids.
       Dosing and Administration of Equipoise
       Medical Equipoise dosages and guidelines are nonexistent due to
       the fact that Equipoise is not currently approved for human use
       as a medicine. Although it was first utilized very briefly
       during the 1970s as a human grade medicine, this is no longer
       the case.
       In the bodybuilding and athletic circles, beginner Equipoise
       dosages are generally in the range of 300 – 500 mg per week,
       followed by 500 – 700mg per week for intermediate dosages.
       Equipoise dosages are usually very similar to Testosterone, and
       venturing higher than the intermediate range is extremely rare,
       especially when the user is utilizing Equipoise alongside other
       compounds within a cycle, which should normally be the case.
       Female anabolic steroid users might find Equipoise a suitable
       compound due to its considerably lower androgenic capabilities
       than Testosterone. In this case, females should find it
       acceptable to use 50 – 75mg per week. However, an issue that may
       present itself is Equipoise’s very long half-life of 14 days,
       which will undoubtedly manifest as a slow reduction of blood
       plasma levels. With this comes a slow elimination of the
       compound from the body, and this can be an issue when/if
       virilization signs and symptoms appear in female users and
       prompt discontinuation of the drug is paramount.
       Being that its half-life is 14 days, it is ideal to split up the
       weekly dosage into two administrations spaced evenly throughout
       the week (for example, 500mg per week administered as 250mg on
       Monday and 250mg on Thursday).
       Equipoise Cycles and Uses
       EQ cycles are usually run as mass gaining cycles that always
       involve the use of at least Testosterone in some form (usually
       the long esters of Testosterone, in order to match-up with EQ’s
       half-life). This is usually done with either Testosterone
       Enanthate or Testosterone Cypionate. Equipoise cycles are also
       normally run for much longer cycle lengths than most other
       compounds, due to the fact that its longer half-life provides a
       slower release and peak-time for effects to be seen.
       Beginner Equipoise cycles normally involve the use of
       Testosterone Enanthate (or Cypionate) at around 300 – 500mg per
       week alongside Equipoise at about 400mg per week. The cycle
       should be run for a total of 14 weeks. This should provide the
       user with a considerable amount of mass gains over the long
       term. Intermediate Equipoise cycles can involve the added use of
       an oral compound, usually Dianabol (Methandrostenolone) at about
       25mg per day. Testosterone Enanthate (or Cypionate) in this case
       can be reduced to 100mg per week in order to merely maintain
       normal physiological function, and Equipoise can be run at about
       400 – 600mg per week. The Dianabol in this case is run from
       weeks 1 – 4, and the total cycle length is 12 weeks.
       Advanced Equipoise cycles usually do not see the use of EQ at
       dosages above 600mg per week. Much like the intermediate
       Equipoise cycles, Testosterone can be run at TRT (Testosterone
       Replacement Therapy) dosages of around 100mg per week, and an
       advanced compound can be used alongside everything, such as
       Trenbolone Enanthate at 400mg per week. Total cycle length would
       be 12 weeks.
       Equipoise Legality
       USA: In the United States, Equipoise is classified as a Schedule
       III drug in the Controlled Substances Act whereby possession and
       use of EQ or any Testosterone product without a valid
       prescription would be considered a felony. Needless to say,
       trafficking, importation, and the purchase of EQ or any anabolic
       steroid is a criminal act.
       UK/England: In the United Kingdom, Equipoise falls under
       Schedule IV, whereby possession and use of Equipoise without a
       physician’s prescription is legal for personal use. Importation
       of Equipoise for personal use without a prescription is also not
       a felony.
       Canada: Canadian law is similar to the UK, where it is a
       Schedule IV drug, and as such, possession and use of Equipoise
       for personal use without a valid physician’s prescription is not
       a felony and is legal. However, trafficking of the substance is
       a felony.
       These are 3 examples of the current state of laws under which EQ
       falls into within 3 major countries in the world. Whichever
       route one decides to acquire Equipoise through, he or she must
       be aware of the legality and laws surrounding it in whichever
       country the person resides. It is important to research
       beforehand in order to make the appropriate decisions and what
       to expect. Ignorance of the law is no excuse.
       How to Buy Equipoise
       Equipoise is moderate in popularity and usage among athletes and
       bodybuilders, and it is very rare that a source or vendor would
       not carry this product. No pharmaceutical grade for-human-use
       Equipoise products currently exist. Therefore, on the anabolic
       steroid black market, there will only be veterinary and UGL
       (Underground Laboratory) grade Equipoise for those looking to
       buy it. It is available in a vast variety of different forms,
       concentrations, dosages, and vials sizes – probably more so than
       any other anabolic steroid available. It would therefore be
       futile to list every single one here. Equipoise is available,
       for example, in 10ml, 50ml, 100ml, 250ml, and even 500ml vials.
       It is commonly concentrated at 200mg/ml, although some
       underground laboratories have manufactured 250mg/ml Equipoise
       products, and even higher concentrations exist.
       Those looking to buy EQ will usually run into the following
       price ranges: on the highest end, EQ can sell for $150 – $170
       for a single 10ml vial containing 200mg/ml of underground
       quality. At its low end, underground Equipoise can be found for
       $60 – $100 for the same type of product (10ml vial containing
       200mg/ml). Veterinary Equipoise at its highest price range can
       be found for $17 – $20 per 1ml glass ampoule containing 50mg/ml.
       At its lowest price range, the same veterinary product can be
       fou
       *****************************************************